These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16297153)

  • 1. Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris.
    Mimouni D; Blank M; Ashkenazi L; Milner Y; Frusic-Zlotkin M; Anhalt GJ; David M; Shoenfeld Y
    Clin Exp Immunol; 2005 Dec; 142(3):426-32. PubMed ID: 16297153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.
    Mimouni D; Blank M; Payne AS; Anhalt GJ; Avivi C; Barshack I; David M; Shoenfeld Y
    Clin Exp Immunol; 2010 Dec; 162(3):543-9. PubMed ID: 20964642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation.
    Kawasaki H; Tsunoda K; Hata T; Ishii K; Yamada T; Amagai M
    J Invest Dermatol; 2006 Dec; 126(12):2621-30. PubMed ID: 16841036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for experimental models of Pemphigus vulgaris.
    Cirillo N; Gombos F; Ruocco V; Lanza A
    Arch Dermatol Res; 2007 Apr; 299(1):9-12. PubMed ID: 17377799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro pathogenicity assay for anti-desmoglein autoantibodies in pemphigus.
    Ishii K; Amagai M
    Methods Mol Biol; 2013; 961():219-25. PubMed ID: 23325646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3).
    Memar O; Christensen B; Rajaraman S; Goldblum R; Tyring SK; Brysk MM; McCormick DJ; el-Zaim H; Fan JL; Prabhakar BS
    J Immunol; 1996 Oct; 157(7):3171-7. PubMed ID: 8816430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
    Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
    Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides.
    Dworschak J; Recke A; Freitag M; Ludwig RJ; Langenhan J; Kreuzer OJ; Zillikens D; Schmidt E
    J Dermatol Sci; 2012 Feb; 65(2):102-9. PubMed ID: 22261006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four mild but refractory cases of pemphigus foliaceus successfully treated with intravenous immunoglobulin.
    Kawakami T; Koga H; Saruta H; Ueda A; Inoue Y; Soma Y; Ishii N; Hashimoto T
    J Dermatol; 2013 Nov; 40(11):869-73. PubMed ID: 24127870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.
    Arnold DF; Burton J; Shine B; Wojnarowska F; Misbah SA
    Br J Dermatol; 2009 May; 160(5):1098-102. PubMed ID: 19222460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris.
    Lo AS; Mao X; Mukherjee EM; Ellebrecht CT; Yu X; Posner MR; Payne AS; Cavacini LA
    PLoS One; 2016; 11(6):e0156800. PubMed ID: 27304671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris.
    Daneshpazhooh M; Kamyab K; Kalantari MS; Balighi K; Naraghi ZS; Shamohammadi S; Mortazavizadeh SM; Ramezani A; Chams-Davatchi C
    Clin Exp Dermatol; 2014 Jan; 39(1):41-7. PubMed ID: 23782219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance.
    Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Hisata K; Iwatsuki K
    Br J Dermatol; 2012 Aug; 167(2):252-61. PubMed ID: 22404487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic human monoclonal antibody against desmoglein 3.
    Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
    Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
    Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
    Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
    J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune dysregulation of pemphigus in humans and mice.
    Yokoyama T; Amagai M
    J Dermatol; 2010 Mar; 37(3):205-13. PubMed ID: 20507383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.